Johnson & Johnson (NYSE:JNJ) is a healthcare Goliath that generates billions of dollars in revenue from consumer goods, pharmaceuticals, and medical devices. In the third quarter, the company's sales of those products allowed it to outpace analyst estimates. Can J&J continue to reward investors with upside?
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,